JP2014524437A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524437A5
JP2014524437A5 JP2014525931A JP2014525931A JP2014524437A5 JP 2014524437 A5 JP2014524437 A5 JP 2014524437A5 JP 2014525931 A JP2014525931 A JP 2014525931A JP 2014525931 A JP2014525931 A JP 2014525931A JP 2014524437 A5 JP2014524437 A5 JP 2014524437A5
Authority
JP
Japan
Prior art keywords
disease
degenerative neurological
nerve
group
parkinson
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014525931A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524437A (ja
JP5872041B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from KR1020120088778A external-priority patent/KR101405437B1/ko
Publication of JP2014524437A publication Critical patent/JP2014524437A/ja
Publication of JP2014524437A5 publication Critical patent/JP2014524437A5/ja
Application granted granted Critical
Publication of JP5872041B2 publication Critical patent/JP5872041B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014525931A 2011-08-16 2012-08-14 幹細胞由来微小胞を含む神経生成促進用組成物 Active JP5872041B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20110081147 2011-08-16
KR10-2011-0081147 2011-08-16
KR1020120088778A KR101405437B1 (ko) 2011-08-16 2012-08-14 줄기세포 유래 미세소포를 포함하는 신경 생성 촉진용 조성물
PCT/KR2012/006478 WO2013025042A2 (ko) 2011-08-16 2012-08-14 줄기세포 유래 미세소포를 포함하는 신경 생성 촉진용 조성물
KR10-2012-0088778 2012-08-14

Publications (3)

Publication Number Publication Date
JP2014524437A JP2014524437A (ja) 2014-09-22
JP2014524437A5 true JP2014524437A5 (enExample) 2015-07-16
JP5872041B2 JP5872041B2 (ja) 2016-03-01

Family

ID=47897528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014525931A Active JP5872041B2 (ja) 2011-08-16 2012-08-14 幹細胞由来微小胞を含む神経生成促進用組成物

Country Status (5)

Country Link
US (2) US20150045298A1 (enExample)
EP (1) EP2745840B1 (enExample)
JP (1) JP5872041B2 (enExample)
KR (1) KR101405437B1 (enExample)
WO (1) WO2013025042A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201302468D0 (en) * 2013-02-12 2013-03-27 Reneuron Ltd Stem cell product
JP2015514760A (ja) * 2012-04-16 2015-05-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 胚性幹細胞微小胞を用いる眼科治療法
WO2014054917A1 (ko) * 2012-10-05 2014-04-10 사회복지법인 삼성생명공익재단 허혈혈청을 포함하는 줄기세포 활성화 촉진용 조성물 및 줄기세포의 활성화 촉진 방법
GB201317887D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product
EP3081223B1 (en) * 2013-12-12 2020-02-19 Samsung Life Public Welfare Foundation Method for promoting generation of stem cell-derived exosome by using thrombin
CN105520911A (zh) * 2014-09-30 2016-04-27 重庆润泽医药有限公司 一种奥拉西坦脂质微泡及其制备方法
JP6800859B2 (ja) 2015-01-26 2020-12-16 フェイト セラピューティクス，インコーポレイテッド 造血細胞分化を誘導するための方法および組成物
CN115927199A (zh) 2015-11-04 2023-04-07 菲特治疗公司 用于诱导造血细胞分化的方法和组合物
US20190060367A1 (en) * 2016-03-03 2019-02-28 Henry Ford Health System 3-d collagen scaffold-generated exosomes and uses thereof
EP3308795A1 (en) 2016-10-12 2018-04-18 Unicyte EV AG A composition of extracellular vesicles (evs) and medical uses thereof
EP3568143B1 (en) * 2017-01-11 2023-12-13 Paracelsus Medizinische Privatuniversität Salzburg - Privatstiftung Mesenchymal stem cell-derived extracellular vesicles and their medical use
KR102184722B1 (ko) * 2018-01-31 2020-12-01 서울대학교산학협력단 성체줄기세포 유래의 나노베시클 및 이의 표적 치료용 용도
WO2020021312A1 (en) 2018-07-26 2020-01-30 Uniwersytet Jagiellonski In vivo delivery system of the genome dna modifying enzymes and the use thereof
KR102320800B1 (ko) * 2018-10-25 2021-11-02 사회복지법인 삼성생명공익재단 효능이 증진된 줄기세포 유래 미세소포, 이의 용도 및 효능강화 방법
US11351119B2 (en) 2018-10-25 2022-06-07 Samsung Life Public Welfare Foundation Stem cell-derived microvesicles with enhanced efficacy, use thereof, and method for enhancing efficacy
CN114306238A (zh) * 2020-09-29 2022-04-12 中山大学 囊泡在制备治疗肺部疾病的药物中的应用
KR20230047936A (ko) * 2021-10-01 2023-04-10 주식회사 입셀 유도만능줄기세포 배양 배지 유래 성분을 포함하는 조성물 내지 이의 용도
WO2024090922A1 (ko) * 2022-10-24 2024-05-02 주식회사 디자인셀 줄기세포 배양액 및 상기로부터 분리된 세포외소포를 유효성분으로 포함하는 뇌신경계 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007285057B2 (en) * 2006-08-15 2013-08-01 Agency For Science, Technology And Research Mesenchymal stem cell conditioned medium
WO2009050742A1 (en) 2007-10-15 2009-04-23 Fresenius Medial Care Deutschland Gmbh Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method
ES2523098T3 (es) * 2007-10-29 2014-11-20 Fresenius Medical Care Deutschland Gmbh Microvesícula (MV) derivada de células madre para su uso en la inhibición de la apoptosis inducida por un agente citostático
US20110014251A1 (en) * 2008-01-04 2011-01-20 Lydac Neuroscience Limited Microvesicles
CN104127438B (zh) * 2008-02-22 2021-01-08 新加坡科技研究局 间充质干细胞颗粒
JP2012512846A (ja) * 2008-12-19 2012-06-07 セリェリクス、ソシエダッド、アノニマ 脂肪幹細胞を含んでなる組成物
US20120177574A1 (en) * 2009-07-01 2012-07-12 Aeon Medix Inc. Microvesicles derived from nucleated, mammalian cells and use thereof
EP2496711B1 (en) * 2009-11-02 2016-02-17 Agency For Science, Technology And Research Methods for monitoring cellular states and for immortalizing mesenchymal stem cells

Similar Documents

Publication Publication Date Title
JP2014524437A5 (enExample)
BR112015023267A8 (pt) composto, e medicamento para tratar um indivíduo com doença ou condição lisofosfatídica dependente de ácido
JOP20210207A1 (ar) مركبات ترابطية مستهدفة
UA113641C2 (xx) Інгібітори бета-секретази
PH12016501600A1 (en) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease
JOP20200050A1 (ar) عوامل RNAi وتركيبات لتثبيط التعبير عن شبيه آنجيوبويتين 3 (ANGPTL3)، وطرق استخدام
EA201790817A1 (ru) 2-амино-3,5-дифтор-3,6-диметил-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы bace1 для лечения болезни альцгеймера
WO2015164750A3 (en) Compositions and methods to treating hemoglobinopathies
EA201390826A1 (ru) ПИРИМИДИНОНОВЫЕ СОЕДИНЕНИЯ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ИЛИ СОСТОЯНИЙ, ОПОСРЕДОВАННЫХ Lp-PLA
MX354662B (es) Anticuerpos fosfoespecificos que reconocen la tau.
PH12013500615A1 (en) Phosphospecific antibodies recognising tau
UA113186C2 (xx) Макроциклічні інгібітори lrrk2 кінази
EP4349854A3 (en) Pd1-cd28 fusion proteins and their use in medicine
PH12013502262A1 (en) Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
WO2008157791A3 (en) Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
EA201790818A1 (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы bace1
TW201613932A (en) Organic compounds
MA44948A1 (fr) Inhibiteurs de bace 1
EA201791030A1 (ru) 2-амино-5,5-дифтор-6-(фторметил)-6-фенил-3,4,5,6-тетрагидпропиридины в качестве ингибиторов bace1
EP2796142A4 (en) PHARMACEUTICAL COMPOSITION WITH DEATH CELLS FROM LACTOBACILLUS ACIDOPHILUS LB STRAIN FOR THE TREATMENT OR PREVENTION OF ALLERGIES
WO2017190044A8 (en) Methods for detecting and treating pain using brain activity
WO2016022536A3 (en) Inhibitors of myh7b and uses thereof
EA201492097A1 (ru) 5-амино[1,4]тиазины в качестве ингибиторов бета-секретазы 1
EA201590410A1 (ru) Ингибиторы бета-секретазы
WO2016183593A3 (en) Prenatal therapy